Home > Actinic Keratosis
Actinic keratosis, also called solar keratosis, is a skin growth that develops in sun-exposed skin, especially on the face, hands, forearms, and the neck. It is seen most often in pale-skinned, fair-haired, light-eyed people, beginning at age 30 or 40 and becoming more common with age.
Actinic keratoses are small and noticeable red, brown, or skin-colored patches that don't go away. They commonly occur on the head, neck, or hands but can be found on other areas of the body. Usually more than one is present. They may:
Actinic keratosis needs to be evaluated by a doctor, especially if the keratoses become painful, bleed, become open sores, become infected, or increase in size.
Actinic keratosis is diagnosed through a skin examination. Your doctor may use a bright light or magnifying lens to look for growths, moles, or lesions. The scalp is examined by parting the hair. If there is a possibility of cancer, your doctor may take a sample of your skin and test (biopsy) it.
Your doctor may recommend one of these treatments:
Actinic keratosis may turn into skin cancer, but this isn't common. There is no way to find out whether actinic keratosis will progress to squamous cell carcinoma or how fast this might occur. Keratoses on the ear and lip are at the highest risk of developing into cancer because of the sensitivity of the ear and lip to sun exposure.
You can help prevent actinic keratosis by staying out of the sun and using sunscreen when you are in the sun. You should also examine your skin for the condition and other suspicious growths once a month, especially if you spend a lot of time in the sun.
To protect your skin:
Other Works Consulted
Duncan KO, et al. (2012). Epithelial precancerous lesions. In LA Goldman et al., eds., Fitzpatrick's Dermatology in General Medicine, 8th ed., vol. 1, pp. 1261-1283. New York: McGraw-Hill.
Kose O, et al. (2008). Comparison of the efficacy and tolerability of 3% diclofenac sodium gel and 5% imiquimod cream in the treatment of actinic keratosis. Journal of Dermatological Treatment, 19(3): 159-163.
ByHealthwise StaffPrimary Medical ReviewerE. Gregory Thompson, MD - Internal MedicineAdam Husney, MD - Family MedicineMartin J. Gabica, MD - Family MedicineSpecialist Medical ReviewerAmy McMichael, MD - Dermatology
Current as ofOctober 5, 2017
Current as of:
October 5, 2017
E. Gregory Thompson, MD - Internal Medicine & Adam Husney, MD - Family Medicine & Martin J. Gabica, MD - Family Medicine & Amy McMichael, MD - Dermatology
To learn more about Healthwise, visit Healthwise.org.
© 1995-2018 Healthwise, Incorporated. Healthwise, Healthwise for every health decision, and the Healthwise logo are trademarks of Healthwise, Incorporated.
301 S 28th Ave
Hattiesburg, MS 39401, MS 39401
CONNECT WITH FORREST HEALTH
Notice of Privacy Practices · PUBLIC RECORDS REQUEST · FINANCIAL ASSISTANCE · NON-DISCRIMINATION NOTICE
REQUEST FROM LAW ENFORCEMENT FOR RELEASE OF PROTECTED HEALTH INFORMATION 6051 US HIGHWAY 49, HATTIESBURG MS 39401 · 601-288-7000 · © FORREST HEALTH · ALL RIGHTS RESERVED ·